Welcome to DU!
The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards.
Join the community:
Create a free account
Support DU (and get rid of ads!):
Become a Star Member
Latest Breaking News
Editorials & Other Articles
General Discussion
The DU Lounge
All Forums
Issue Forums
Culture Forums
Alliance Forums
Region Forums
Support Forums
Help & Search
After ruling, the future of abortion pills rests with Biden or Trump
Last edited Fri Jun 14, 2024, 06:26 AM - Edit history (3)
After ruling, the future of abortion pills rests with Biden or Trump
Antiabortion advocates hope Trump endorses restrictions after the Supreme Court refused to limit access to a key abortion drug.
By Caroline Kitchener and Michael Scherer
June 13, 2024 at 5:24 p.m. EDT
Share
https://wapo.st/4bU0ZdQ
The Supreme Court’s decision Thursday not to impose restrictions on a key abortion drug, while a victory for abortion rights advocates, crystallizes the stakes of the next presidential election for access nationwide. … Because a president has enormous power to influence federal agencies that oversee abortion policy, a potential Trump administration could unilaterally choose to do what the Supreme Court did not: impose strict restrictions on mifepristone, one of two drugs used in over 60 percent of abortions — or even move to take the drug off the market entirely.
“This decision means the ball is squarely in the next administration’s court,” said Roger Severino, who oversees abortion policy at the conservative Heritage Foundation and led abortion-related initiatives in the Department of Health and Human Services under Trump. “It’s up to the next administration to restore some semblance of safety to this largely unregulated regime of chemical abortion.”
{snip}
Antiabortion advocates have grown increasingly frustrated that the landmark 2022 ruling in Dobbs v. Jackson Women’s Health Organization overturning a right to abortion has done little to decrease the number of abortions nationwide — with more abortions occurring in 2023 than ever before. Experts say the rise of abortion pills has contributed significantly to that trend, with many women now able to access abortion by mail, including in states where the procedure is illegal.
{snip}
.
“The FDA should revisit chemical abortion — and be driven by the science and the law, and not take anything off the table,” said Severino, who wrote the chapter of the Heritage document, titled “Project 2025,” that deals with abortion pills.
{snip}
Share
https://wapo.st/4bU0ZdQ
Beth Reinhard and Marianna Sotomayor contributed to this report.
By Caroline Kitchener
Caroline Kitchener is a reporter covering abortion at The Washington Post. She won the 2023 Pulitzer Prize for National Reporting. Twitter https://twitter.com/amarimow
By Michael Scherer
Michael Scherer is a national political reporter at The Washington Post. He was previously the Washington bureau chief for Time magazine, where he also served as the White House correspondent. Before joining Time, he was the Washington correspondent for Salon.com. Twitter https://twitter.com/CAKitchener
Antiabortion advocates hope Trump endorses restrictions after the Supreme Court refused to limit access to a key abortion drug.
By Caroline Kitchener and Michael Scherer
June 13, 2024 at 5:24 p.m. EDT
Share
https://wapo.st/4bU0ZdQ
The Supreme Court’s decision Thursday not to impose restrictions on a key abortion drug, while a victory for abortion rights advocates, crystallizes the stakes of the next presidential election for access nationwide. … Because a president has enormous power to influence federal agencies that oversee abortion policy, a potential Trump administration could unilaterally choose to do what the Supreme Court did not: impose strict restrictions on mifepristone, one of two drugs used in over 60 percent of abortions — or even move to take the drug off the market entirely.
“This decision means the ball is squarely in the next administration’s court,” said Roger Severino, who oversees abortion policy at the conservative Heritage Foundation and led abortion-related initiatives in the Department of Health and Human Services under Trump. “It’s up to the next administration to restore some semblance of safety to this largely unregulated regime of chemical abortion.”
{snip}
Antiabortion advocates have grown increasingly frustrated that the landmark 2022 ruling in Dobbs v. Jackson Women’s Health Organization overturning a right to abortion has done little to decrease the number of abortions nationwide — with more abortions occurring in 2023 than ever before. Experts say the rise of abortion pills has contributed significantly to that trend, with many women now able to access abortion by mail, including in states where the procedure is illegal.
{snip}
.
“The FDA should revisit chemical abortion — and be driven by the science and the law, and not take anything off the table,” said Severino, who wrote the chapter of the Heritage document, titled “Project 2025,” that deals with abortion pills.
{snip}
Share
https://wapo.st/4bU0ZdQ
Beth Reinhard and Marianna Sotomayor contributed to this report.
By Caroline Kitchener
Caroline Kitchener is a reporter covering abortion at The Washington Post. She won the 2023 Pulitzer Prize for National Reporting. Twitter https://twitter.com/amarimow
By Michael Scherer
Michael Scherer is a national political reporter at The Washington Post. He was previously the Washington bureau chief for Time magazine, where he also served as the White House correspondent. Before joining Time, he was the Washington correspondent for Salon.com. Twitter https://twitter.com/CAKitchener
2 replies
= new reply since forum marked as read
= new reply since forum marked as read
